Promising new research published in PNAS on 29 July 2026 could help reshape the future of snakebite treatment by pointing scientists toward a more effective way of developing antivenoms against some of the world’s deadliest snakes. Snakebite envenoming remains a major but often overlooked health emergency, especially in rural parts of Africa, Asia and Latin America, where delayed access to treatment can turn a bite into a life-threatening crisis within hours. The new findings suggest that researchers may be able to produce more potent and targeted antivenom approaches, potentially improving how venom toxins are neutralised and increasing the chances of survival for patients who currently depend on older, sometimes less precise treatments. This matters deeply for many African communities, where snakebite continues to kill and disable farmers, herders, children and rural workers, while health facilities often face shortages of antivenom and long referral delays. Better antivenom science could mean not only more lives saved, but also fewer amputations, less long-term disability and stronger emergency care in regions where snakebite is both a medical and social burden. While more work is still needed before the research changes frontline treatment everywhere, the study adds real momentum to a field that could bring faster, safer and more effective protection against one of tropical medicine’s most neglected killers.